RecruitingNCT07385443

The Spanish National Registry for Myotonic Dystrophy Type 1

Creación de un Nodo Integral Para la Distrofia Miotónica Tipo 1 en España: Registro clínico, Mapas genómicos, epigenómicos y proteómicos (DM1-Hub)


Sponsor

Fundació Institut Germans Trias i Pujol

Enrollment

3,000 participants

Start Date

Jun 2, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Myotonic Dystrophy Type 1 (DM1) is a rare genetic neuromuscular condition that can affect multiple organs and varies widely in how it presents. DM1 is the most common form of adult-onset muscular dystrophy, with an estimated prevalence of approximately 1-5 per 10,000 people. In Spain, the condition shows notable regional differences, making it especially important to understand its characteristics within the population. The aim of this study is to support a research initiative designed to better characterise DM1. We are developing a comprehensive national registry, collecting patient-reported information, clinical data and omics data that will improve our understanding of the disease and help identify individuals who may be eligible for clinical trials.


Eligibility

Inclusion Criteria1

  • Confirmed diagnosis of Myotonic Dystrophy Type 1 (DM1) through genetic testing.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERPatient Registry

Patient Registry


Locations(8)

Hospitals within the DM1 network

Multiple Locations, Andalusia, Spain

Hospitals within the DM1 network

Multiple Locations, Basque Country, Spain

Hospitals within the DM1 network

Multiple Locations, Canary Islands, Spain

Hospitals within the DM1 network

Multiple Locations, Cantabria, Spain

Hospitals within the DM1 network

Multiple Locations, Castilla-La Macha, Spain

Hospitals within the DM1 network

Multiple Locations, Catalonia, Spain

Hospitals within the DM1 network

Multiple Locations, Madrid, Spain

Hospitals within the DM1 network

Multiple Locations, Valencia, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07385443


Related Trials